TARS vs UBER
Tarsus Pharmaceuticals Inc (TARS) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported TARS revenue for 2024-12-31 was $183.0M. Net income was -$115.6M. Revenue was up 948.6% from 2023-12-31 to 2024-12-31. TARS currently screens at market cap $2.66B.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
TARS currently screens at market cap $2.66B. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the TARS and UBER stock pages for the full models.
Not investment advice.